Copyright Reports & Markets. All rights reserved.

Global Drug Abuse Screening Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Drug Abuse Screening by Type
    • 1.3.1 Overview: Global Drug Abuse Screening Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Drug Abuse Screening Consumption Value Market Share by Type in 2024
    • 1.3.3 Urine Sample
    • 1.3.4 Breath Sample
    • 1.3.5 Oral Fluid Sample
    • 1.3.6 Hair Sample
  • 1.4 Global Drug Abuse Screening Market by Application
    • 1.4.1 Overview: Global Drug Abuse Screening Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Drug Testing Laboratories
    • 1.4.3 Hospital
    • 1.4.4 Others
  • 1.5 Global Drug Abuse Screening Market Size & Forecast
  • 1.6 Global Drug Abuse Screening Market Size and Forecast by Region
    • 1.6.1 Global Drug Abuse Screening Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Drug Abuse Screening Market Size by Region, (2020-2031)
    • 1.6.3 North America Drug Abuse Screening Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Drug Abuse Screening Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Drug Abuse Screening Market Size and Prospect (2020-2031)
    • 1.6.6 South America Drug Abuse Screening Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Drug Abuse Screening Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Drug Abuse Screening Product and Solutions
    • 2.1.4 Abbott Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.2 Bio-Rad Laboratories
    • 2.2.1 Bio-Rad Laboratories Details
    • 2.2.2 Bio-Rad Laboratories Major Business
    • 2.2.3 Bio-Rad Laboratories Drug Abuse Screening Product and Solutions
    • 2.2.4 Bio-Rad Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.3 Clinical Reference Laboratory
    • 2.3.1 Clinical Reference Laboratory Details
    • 2.3.2 Clinical Reference Laboratory Major Business
    • 2.3.3 Clinical Reference Laboratory Drug Abuse Screening Product and Solutions
    • 2.3.4 Clinical Reference Laboratory Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Clinical Reference Laboratory Recent Developments and Future Plans
  • 2.4 Laboratory Corporation of America Holdings
    • 2.4.1 Laboratory Corporation of America Holdings Details
    • 2.4.2 Laboratory Corporation of America Holdings Major Business
    • 2.4.3 Laboratory Corporation of America Holdings Drug Abuse Screening Product and Solutions
    • 2.4.4 Laboratory Corporation of America Holdings Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
  • 2.5 Legacy Medical Services
    • 2.5.1 Legacy Medical Services Details
    • 2.5.2 Legacy Medical Services Major Business
    • 2.5.3 Legacy Medical Services Drug Abuse Screening Product and Solutions
    • 2.5.4 Legacy Medical Services Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Legacy Medical Services Recent Developments and Future Plans
  • 2.6 LGC Group
    • 2.6.1 LGC Group Details
    • 2.6.2 LGC Group Major Business
    • 2.6.3 LGC Group Drug Abuse Screening Product and Solutions
    • 2.6.4 LGC Group Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 LGC Group Recent Developments and Future Plans
  • 2.7 Mayo Clinic Laboratories
    • 2.7.1 Mayo Clinic Laboratories Details
    • 2.7.2 Mayo Clinic Laboratories Major Business
    • 2.7.3 Mayo Clinic Laboratories Drug Abuse Screening Product and Solutions
    • 2.7.4 Mayo Clinic Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Mayo Clinic Laboratories Recent Developments and Future Plans
  • 2.8 Millennium Health
    • 2.8.1 Millennium Health Details
    • 2.8.2 Millennium Health Major Business
    • 2.8.3 Millennium Health Drug Abuse Screening Product and Solutions
    • 2.8.4 Millennium Health Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Millennium Health Recent Developments and Future Plans
  • 2.9 Omega Laboratories
    • 2.9.1 Omega Laboratories Details
    • 2.9.2 Omega Laboratories Major Business
    • 2.9.3 Omega Laboratories Drug Abuse Screening Product and Solutions
    • 2.9.4 Omega Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Omega Laboratories Recent Developments and Future Plans
  • 2.10 Precision Diagnostics
    • 2.10.1 Precision Diagnostics Details
    • 2.10.2 Precision Diagnostics Major Business
    • 2.10.3 Precision Diagnostics Drug Abuse Screening Product and Solutions
    • 2.10.4 Precision Diagnostics Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Precision Diagnostics Recent Developments and Future Plans
  • 2.11 Psychemedics
    • 2.11.1 Psychemedics Details
    • 2.11.2 Psychemedics Major Business
    • 2.11.3 Psychemedics Drug Abuse Screening Product and Solutions
    • 2.11.4 Psychemedics Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Psychemedics Recent Developments and Future Plans
  • 2.12 Quest Diagnostics
    • 2.12.1 Quest Diagnostics Details
    • 2.12.2 Quest Diagnostics Major Business
    • 2.12.3 Quest Diagnostics Drug Abuse Screening Product and Solutions
    • 2.12.4 Quest Diagnostics Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.13 Sonic Healthcare
    • 2.13.1 Sonic Healthcare Details
    • 2.13.2 Sonic Healthcare Major Business
    • 2.13.3 Sonic Healthcare Drug Abuse Screening Product and Solutions
    • 2.13.4 Sonic Healthcare Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Sonic Healthcare Recent Developments and Future Plans
  • 2.14 United States Drug Testing Laboratories
    • 2.14.1 United States Drug Testing Laboratories Details
    • 2.14.2 United States Drug Testing Laboratories Major Business
    • 2.14.3 United States Drug Testing Laboratories Drug Abuse Screening Product and Solutions
    • 2.14.4 United States Drug Testing Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 United States Drug Testing Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Drug Abuse Screening Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Drug Abuse Screening by Company Revenue
    • 3.2.2 Top 3 Drug Abuse Screening Players Market Share in 2024
    • 3.2.3 Top 6 Drug Abuse Screening Players Market Share in 2024
  • 3.3 Drug Abuse Screening Market: Overall Company Footprint Analysis
    • 3.3.1 Drug Abuse Screening Market: Region Footprint
    • 3.3.2 Drug Abuse Screening Market: Company Product Type Footprint
    • 3.3.3 Drug Abuse Screening Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Drug Abuse Screening Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Drug Abuse Screening Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Drug Abuse Screening Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Drug Abuse Screening Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Drug Abuse Screening Consumption Value by Type (2020-2031)
  • 6.2 North America Drug Abuse Screening Market Size by Application (2020-2031)
  • 6.3 North America Drug Abuse Screening Market Size by Country
    • 6.3.1 North America Drug Abuse Screening Consumption Value by Country (2020-2031)
    • 6.3.2 United States Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Drug Abuse Screening Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Drug Abuse Screening Consumption Value by Type (2020-2031)
  • 7.2 Europe Drug Abuse Screening Consumption Value by Application (2020-2031)
  • 7.3 Europe Drug Abuse Screening Market Size by Country
    • 7.3.1 Europe Drug Abuse Screening Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 7.3.3 France Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Drug Abuse Screening Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Drug Abuse Screening Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Drug Abuse Screening Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Drug Abuse Screening Market Size by Region
    • 8.3.1 Asia-Pacific Drug Abuse Screening Consumption Value by Region (2020-2031)
    • 8.3.2 China Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 8.3.5 India Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Drug Abuse Screening Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Drug Abuse Screening Consumption Value by Type (2020-2031)
  • 9.2 South America Drug Abuse Screening Consumption Value by Application (2020-2031)
  • 9.3 South America Drug Abuse Screening Market Size by Country
    • 9.3.1 South America Drug Abuse Screening Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Drug Abuse Screening Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Drug Abuse Screening Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Drug Abuse Screening Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Drug Abuse Screening Market Size by Country
    • 10.3.1 Middle East & Africa Drug Abuse Screening Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Drug Abuse Screening Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Drug Abuse Screening Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Drug Abuse Screening Market Drivers
  • 11.2 Drug Abuse Screening Market Restraints
  • 11.3 Drug Abuse Screening Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Drug Abuse Screening Industry Chain
  • 12.2 Drug Abuse Screening Upstream Analysis
  • 12.3 Drug Abuse Screening Midstream Analysis
  • 12.4 Drug Abuse Screening Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Drug Abuse Screening market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Drug Abuse Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Drug Abuse Screening market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Drug Abuse Screening market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Drug Abuse Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Drug Abuse Screening market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Drug Abuse Screening
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Drug Abuse Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Bio-Rad Laboratories, Clinical Reference Laboratory, Laboratory Corporation of America Holdings, Legacy Medical Services, LGC Group, Mayo Clinic Laboratories, Millennium Health, Omega Laboratories, Precision Diagnostics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Drug Abuse Screening market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Urine Sample
    Breath Sample
    Oral Fluid Sample
    Hair Sample
    Market segment by Application
    Drug Testing Laboratories
    Hospital
    Others
    Market segment by players, this report covers
    Abbott Laboratories
    Bio-Rad Laboratories
    Clinical Reference Laboratory
    Laboratory Corporation of America Holdings
    Legacy Medical Services
    LGC Group
    Mayo Clinic Laboratories
    Millennium Health
    Omega Laboratories
    Precision Diagnostics
    Psychemedics
    Quest Diagnostics
    Sonic Healthcare
    United States Drug Testing Laboratories
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Drug Abuse Screening product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Drug Abuse Screening, with revenue, gross margin, and global market share of Drug Abuse Screening from 2020 to 2025.
    Chapter 3, the Drug Abuse Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drug Abuse Screening market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Abuse Screening.
    Chapter 13, to describe Drug Abuse Screening research findings and conclusion.

    Buy now